152 related articles for article (PubMed ID: 3212263)
1. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
[No Abstract] [Full Text] [Related]
2. [The use of thymostimulin in lymphoma and myeloma patients].
Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
[TBL] [Abstract][Full Text] [Related]
3. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
[No Abstract] [Full Text] [Related]
4. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
5. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
6. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy].
Alba E; Visentin L; Farina C; Wierdis T
Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
Sommer S
Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
[No Abstract] [Full Text] [Related]
8. [Natulan (experimental and clinical data on its antitumor effect)].
Brodskaia NA
Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
[No Abstract] [Full Text] [Related]
9. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
[No Abstract] [Full Text] [Related]
10. [Quantitative immunoglobulin determination as a monitoring technic in hematologic diseases under cytostatic therapy].
Knolle J; Wörz R; Meyer zum Büschenfelde
Verh Dtsch Ges Inn Med; 1969; 75():492-7. PubMed ID: 4099583
[No Abstract] [Full Text] [Related]
11. [Chemotherapy in non-Hodgkin lymphoma].
Bremer K; Meusers P; Brittinger G
Internist (Berl); 1980 Sep; 21(9):512-28. PubMed ID: 7005175
[No Abstract] [Full Text] [Related]
12. [Study on antineoplastic chemotherapy of malignant lymphoma and the period of survival, with special reference to lymphatic reticulum cell sarcoma].
Sakai Y
Naika; 1968 Sep; 22(3):651-61. PubMed ID: 4884751
[No Abstract] [Full Text] [Related]
13. [Experiences with combined chemotherapy of malignant lymphoma].
Klener P; Donner L
Vnitr Lek; 1975 Oct; 21(10):986-91. PubMed ID: 1242547
[No Abstract] [Full Text] [Related]
14. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
15. Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
Kiss I; Tomasek J
Stem Cells; 1999; 17(4):233-4. PubMed ID: 10437987
[No Abstract] [Full Text] [Related]
16. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
17. Single dose of filgrastim (rhG-CSF) to predict mobilisation of haemopoietic progenitors in patients with haematological malignancies.
Mijovic A; Mufti GJ
Bone Marrow Transplant; 1995 May; 15(5):813-4. PubMed ID: 7545491
[No Abstract] [Full Text] [Related]
18. Treatment of lymphomas with antineoplastic agents.
Brunk SF
J Iowa Med Soc; 1968 Oct; 58(10):1038-41. PubMed ID: 4884154
[No Abstract] [Full Text] [Related]
19. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
20. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
